Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug…
Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer Genmab A/S announced today new datademonstrating thatrinatabart sesutecan (Rina-S®), an investigational folate receptor…
Orum Therapeutics Appoints Dr. Maria Koehler and Geoff Meyerson to Board of Directors Orum Therapeutics, a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the appointment of…
Study Finds Biofield Therapy Slows Pancreatic Cancer Progression and Reduces Metastasis Biofield therapy (BT)—a non-invasive, practitioner-administered therapy—can significantly slow the growth and spread of pancreatic cancer in pre-clinical models, according…
Lineage Announces Formation of Scientific Advisory Board Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious medical conditions, today announced…
Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today highlighted…
AdaptHealth Refinances Credit Facility, Extends Maturity and Lowers Debt Costs AdaptHealth Corp., a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced…
Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria Enanta Pharmaceuticals, Inc., a clinical-stage…
U.S. Grants Priority Review to Ifinatamab Deruxtecan for Previously Treated ES-SCLC Patients After Platinum Therapy Daiichi Sankyo and Merck & Co. have reached an important regulatory milestone with the U.S.…
Johnson & Johnson Presents New TECNIS PureSee IOL Clinical Data Showing Strong Contrast Sensitivity and Extended Vision Range at ASCRS 2026 Johnson & Johnson (NYSE: JNJ) has announced the presentation…
Prothena Corporation plc Reports Updates to Its Leadership Team Prothena Corporation plc (NASDAQ: PRTA), a late-stage biotechnology company focused on developing therapies for diseases driven by protein dysregulation, has announced…
Covalon Technologies Ltd. Highlights Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting Covalon Technologies Ltd., a company specializing in advanced medical technologies for wound care…